Care Capital Offshore Investments II LP
CIK 0001357403 Name as filed on the most recent filing
Filed as Care Capital Offshore Investments II LP (50)
99 transaction lines · from 50 filings · filed 2006-11-21 to 2015-02-25 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Inotek Pharmaceuticals Corp 1 filings
- ISSUER Acura Pharmaceuticals, Inc 42 filings
- ISSUER Vanda Pharmaceuticals Inc. 7 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2013-04-29 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 136,000 disposed | 2.55 | 346,800.00 | Form 4, filing 0001104659-13-035380 | |
| 2013-04-26 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 80,000 disposed | 2.58 | 206,400.00 | Form 4, filing 0001104659-13-035380 | |
| 2013-04-25 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 100,000 disposed | 2.68 | 268,000.00 | Form 4, filing 0001104659-13-033611 | |
| 2013-04-24 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 82,000 disposed | 2.58 | 211,560.00 | Form 4, filing 0001104659-13-033611 | |
| 2013-04-23 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 315,000 disposed | 2.67 | 841,050.00 | Form 4, filing 0001104659-13-032364 | |
| 2013-04-22 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 500,000 disposed | 3.02 | 1,510,000.00 | Form 4, filing 0001104659-13-032364 | |
| 2013-04-17 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 321,682 disposed | 3.33 | 1,071,201.06 | Form 4, filing 0001104659-13-030989 | |
| 2013-04-02 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 7,416 disposed | 2.15 | 15,944.40 | Form 4, filing 0001104659-13-027174 | |
| 2013-03-28 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 10,000 disposed | 2.20 | 22,000.00 | Form 4, filing 0001104659-13-026206 | |
| 2013-03-26 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 27,000 disposed | 2.15 | 58,050.00 | Form 4, filing 0001104659-13-024528 | |
| 2013-03-22 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 12,554 disposed | 2.21 | 27,744.34 | Form 4, filing 0001104659-13-024528 | |
| 2013-03-21 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 86,000 disposed | 2.24 | 192,640.00 | Form 4, filing 0001104659-13-023734 | |
| 2013-03-20 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 17,215 disposed | 2.34 | 40,283.10 | Form 4, filing 0001104659-13-023734 | |
| 2013-03-18 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 31,375 disposed | 2.36 | 74,045.00 | Form 4, filing 0001104659-13-022627 | |
| 2013-03-15 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 59,410 disposed | 2.37 | 140,801.70 | Form 4, filing 0001104659-13-021769 | |
| 2013-03-14 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 59,000 disposed | 2.52 | 148,680.00 | Form 4, filing 0001104659-13-021769 | |
| 2013-03-13 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 29,000 disposed | 2.50 | 72,500.00 | Form 4, filing 0001104659-13-020715 | |
| 2013-03-12 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 44,000 disposed | 2.48 | 109,120.00 | Form 4, filing 0001104659-13-020715 | |
| 2012-03-12 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 9,993 disposed | 3.31 | 33,076.83 | Form 4, filing 0001104659-12-018228 | |
| 2010-03-05 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 10,923 disposed | 4.77 | 52,102.71 | Form 4, filing 0001209191-10-015321 | |
| 2009-05-26 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 10,000 disposed | 7.38 | 73,800.00 | Form 4, filing 0001209191-09-028949 | |
| 2009-05-22 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 5,800 disposed | 7.50 | 43,500.00 | Form 4, filing 0001209191-09-028949 | |
| 2009-05-20 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 6,000 disposed | 7.34 | 44,040.00 | Form 4, filing 0001209191-09-028326 | |
| 2009-05-15 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 1,338 disposed | 7.04 | 9,419.52 | Form 4, filing 0001209191-09-027346 | |
| 2009-05-13 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 7,028 disposed | 7.05 | 49,547.40 | Form 4, filing 0001209191-09-026501 | |
| 2009-05-08 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 10,600 disposed | 6.93 | 73,458.00 | Form 4, filing 0001209191-09-025755 | |
| 2009-05-07 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 12,900 disposed | 6.91 | 89,139.00 | Form 4, filing 0001209191-09-025755 | |
| 2009-05-06 |
Acura Pharmaceuticals, Inc ACUR |
S, Open-market sale | 12,100 disposed | 6.79 | 82,159.00 | Form 4, filing 0001209191-09-025509 | |
| 2007-08-20 |
Acura Pharmaceuticals, Inc ACUR.OB |
P, Open-market purchase | 38,125,924 acquired | Not reported | Not priced | Form 4, filing 0001179110-07-017284 | |
| 2007-08-20 |
Acura Pharmaceuticals, Inc ACUR.OB |
P, Open-market purchase | 38,125,924 acquired | Not reported | Not priced | Form 4, filing 0001179110-07-017204 | |
| 2007-08-20 |
Acura Pharmaceuticals, Inc ACUR.OB |
P, Open-market purchase | 33,333,332 acquired | Not reported | Not priced | Form 4, filing 0001179110-07-017204 | |
| 2006-12-12 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 396,920 disposed | 25.18 | 9,994,445.60 | Form 4, filing 0001104659-06-081557 | |
| 2006-12-12 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 27,230 disposed | 25.18 | 685,651.40 | Form 4, filing 0001104659-06-081557 | |
| 2006-12-11 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 305,375 disposed | 26.40 | 8,061,900.00 | Form 4, filing 0001104659-06-081208 | |
| 2006-12-11 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 20,950 disposed | 26.40 | 553,080.00 | Form 4, filing 0001104659-06-081208 | |
| 2006-11-27 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 280,740 disposed | 14.18 | 3,980,893.20 | Form 4, filing 0001104659-06-078436 | |
| 2006-11-27 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 19,260 disposed | 14.18 | 273,106.80 | Form 4, filing 0001104659-06-078436 | |
| 2006-11-22 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 280,740 disposed | 14.12 | 3,964,048.80 | Form 4, filing 0001104659-06-077748 | |
| 2006-11-22 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 19,260 disposed | 14.12 | 271,951.20 | Form 4, filing 0001104659-06-077748 | |
| 2006-11-21 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 46,790 disposed | 14.55 | 680,794.50 | Form 4, filing 0001104659-06-077463 | |
| 2006-11-21 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 3,210 disposed | 14.55 | 46,705.50 | Form 4, filing 0001104659-06-077463 | |
| 2006-11-20 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 3,210 disposed | 15.29 | 49,080.90 | Form 4, filing 0001104659-06-077459 | |
| 2006-11-20 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 46,790 disposed | 15.29 | 715,419.10 | Form 4, filing 0001104659-06-077459 | |
| 2006-11-20 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 46,790 disposed | 15.29 | 715,419.10 | Form 4, filing 0001104659-06-076972 | |
| 2006-11-20 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 3,210 disposed | 15.29 | 49,080.90 | Form 4, filing 0001104659-06-076972 | |
| 2006-11-17 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 17,334 disposed | 14.25 | 247,009.50 | Form 4, filing 0001104659-06-077459 | |
| 2006-11-17 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 252,666 disposed | 14.25 | 3,600,490.50 | Form 4, filing 0001104659-06-077459 | |
| 2006-11-17 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 252,666 disposed | 14.25 | 3,600,490.50 | Form 4, filing 0001104659-06-076972 | |
| 2006-11-17 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 17,334 disposed | 14.25 | 247,009.50 | Form 4, filing 0001104659-06-076972 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Care Capital Offshore Investments II LP, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001357403
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6